Take Home Medication New York Title 17 NYCRR part 828.11

Part 828.11

New York Title 17 NYCRR

  1. Length of Treatment:

    a. If a patient has been admitted for less than 3 months daily clinic visits are required unless the program is open only 6 days.

    b. More than 3 months but less than 2 years 3 visits a week are required.

    c. More then 2 years but less then 3 years 2 visits per week are required.

    d. More than 3 years 1 visit per week is required.

  2. Adherence to program regulations.

  3. Progress in maintaining a stable life style as evidenced by:

    a. Absence of alcohol or drug abuse.

    b. Regular clinic attendance.

    c. Absence of behavior problems including loitering.

    d. Absence of recent criminal activity.

    e. Employment, school attendance, or other appropriate activity.

  4. Assurance that take-home medication can be safely transported and stored by the patient for his/her use only.

Prior to granting take home privileges, the program physician shall document in the patients record that all the above criteria have been met in his or her opinion the risk of diversion or misuse is outweighed by the rehabilitative benefits to be derived and the patients demonstrated overall responsibility in the handling of methadone.

After Care and Medical Maintenance

    If you have been in treatment for 4 years, are currently on once a week for at least a year, and are employed, you may be qualified for After Care (twice a month pick up) or Medical Maintenance (twice a month going to a doctor’s office). Ask you counselor or contact the National Alliance of Methadone Advocates.

Similar Posts

  • Press Conference Wednesday, October 10th

    Admin 05/27/2021

    Press Conference Wednesday, October 10th Jeanne Henry Director Office of Public Affairs State of Missouri, Department of Mental Health The last day of the conference the Missouri Department of Mental Health’s Office of Public Affairs interviewed many of the luminaries attending the conference. Included in the interviews were Joycelyn Woods, Howard Lotsof and Barbara Finger….

  • Find Treatment

    Admin 04/21/2021

    Find Select or search by facility name Near Radius: 15 miles Suggested Filters CCAPPCCAPP EducationOnline EducationRecovery Residences (Sober Living)65+Treatment CenterShowersMedicaidUnder 18Addiction and SUD ServicesMental Health ServicesRecovery Organizations (RO)CCAPP SchoolCCAPP Recovery Residences Don’t see your facility?Click here to get listed Available beds at this house Weingart Center – San Pedro Street Los Angeles CA, 90013 100…

  • Join iGive

    Admin 06/06/2023

    By joining iGive and shopping for NAMA-R you are getting great merchandise, it is easier to shop and of course the karma you get can’t be discounted either. Here are some ideas for shopping at iGive:   Buy your home office supplies at Staples or Office Depot. If there is anything you purchase on the…

  • CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

    Admin 06/23/2021

    The Basic Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment. Regulations and Accreditation The federal regulations will be explained:  What they are and…

  • Email Protection

    Admin 08/08/2022

    Please enable cookies. You are unable to access this email address Methadone.org The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode…

  • Page 4098 Federal Register

    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…